Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.8300
+0.0020 (0.24%)
Apr 10, 2026, 2:18 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 282.19 million as of April 10, 2026. Its market cap has decreased by -21.89% in one year.
Market Cap
282.19M
Enterprise Value
121.37M
Revenue
20.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.83
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 282.19M, an increase of 228.92%. That is a compound annual growth rate of 14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 282.19M | -10.39% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 418.78M |
| Ascelia Pharma AB | 367.29M |
| Bio-Works Technologies AB | 347.99M |
| Sprint Bioscience AB | 311.27M |
| Mendus AB | 287.11M |
| Elicera Therapeutics AB | 263.55M |
| Diamyd Medical AB | 256.65M |
| Xintela AB | 235.13M |